Recombinant Proteins

Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.

Search Within Results

1,711 – 1,725 of 129,074 results

1,711

Invitrogen™ Human NARFL (aa 250-343) Control Fragment Recombinant Protein

Recombinant Protein

Pricing & Availability

1,712

Invitrogen™ Human IGSF6 (aa 180-241) Control Fragment Recombinant Protein

Recombinant Protein

Pricing & Availability

1,713

Invitrogen™ Human RGS11 (aa 177-264) Control Fragment Recombinant Protein

Recombinant Protein

Pricing & Availability

1,714

Invitrogen™ Human LYPLA3 (aa 306-384) Control Fragment Recombinant Protein

Recombinant Protein

Pricing & Availability

1,715

Invitrogen™ Human RGS11 (aa 14-105) Control Fragment Recombinant Protein

Recombinant Protein

Pricing & Availability

1,716

Invitrogen™ Human DEXI (aa 50-95) Control Fragment Recombinant Protein

Recombinant Protein

Pricing & Availability

1,717

Invitrogen™ Human STUB1 (aa 232-303) Control Fragment Recombinant Protein

Recombinant Protein

Pricing & Availability

1,718

Invitrogen™ Human CRAMP1L (aa 806-904) Control Fragment Recombinant Protein

Recombinant Protein

Pricing & Availability

1,719

Invitrogen™ Human Coronin 7 (aa 753-853) Control Fragment Recombinant Protein

Recombinant Protein

Pricing & Availability

1,720

R&D Systems™ Recombinant Human IL-10 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Pricing & Availability
Specifications

Purity or Quality Grade	>97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
Conjugate	Unconjugated
Molecular Weight (g/mol)	18.6 kDa
Gene Symbol	IL10
Endotoxin Concentration	<0.10 EU per 1 μg of the protein by the LAL method.
Storage Requirements	Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution
For Use With (Application)	Bioactivity
Source	<EM>Spodoptera frμgiperda</EM>, <EM>Sf</EM> 21 (baculovirus)-derived human IL-10 protein Ser19-Asn178
Accession Number	P22301
Regulatory Status	RUO
Gene Alias	CSIF, CSIFMGC126450, Cytokine synthesis inhibitory factor, GVHDS, IL10, IL10A, IL-10MGC126451, interleukin 10, interleukin-10, TGIF
Gene ID (Entrez)	3586
Formulation	Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. *1 mg pack size (01M) is supplied as a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Reconstitution	Reconstitute at 50 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Cross Reactivity	IL-10
Species	Human